34 related articles for article (PubMed ID: 1835412)
1. Differential Localization and Invasion of Tumor Cells in Mouse Models of Human and Murine Leukemias.
Mashima K; Azuma M; Fujiwara K; Inagaki T; Oh I; Ikeda T; Umino K; Nakano H; Morita K; Sato K; Minakata D; Yamasaki R; Ashizawa M; Yamamoto C; Fujiwara SI; Hatano K; Ohmine K; Muroi K; Ohno N; Kanda Y
Acta Histochem Cytochem; 2020 Jun; 53(3):43-53. PubMed ID: 32624629
[TBL] [Abstract][Full Text] [Related]
2. Bromodomains and Extra-Terminal (BET) Inhibitor JQ1 Suppresses Proliferation of Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolysis.
Zhang MY; Liu SL; Huang WL; Tang DB; Zheng WW; Zhou N; Zhou H; Abudureheman T; Tang ZH; Zhou BS; Duan CW
Med Sci Monit; 2020 Apr; 26():e923411. PubMed ID: 32266878
[TBL] [Abstract][Full Text] [Related]
3. Stability of gene expression and epigenetic profiles highlights the utility of patient-derived paediatric acute lymphoblastic leukaemia xenografts for investigating molecular mechanisms of drug resistance.
Wong NC; Bhadri VA; Maksimovic J; Parkinson-Bates M; Ng J; Craig JM; Saffery R; Lock RB
BMC Genomics; 2014 Jun; 15(1):416. PubMed ID: 24885906
[TBL] [Abstract][Full Text] [Related]
4. Murine models of acute leukemia: important tools in current pediatric leukemia research.
Jacoby E; Chien CD; Fry TJ
Front Oncol; 2014; 4():95. PubMed ID: 24847444
[TBL] [Abstract][Full Text] [Related]
5. High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias.
Morisot S; Wayne AS; Bohana-Kashtan O; Kaplan IM; Gocke CD; Hildreth R; Stetler-Stevenson M; Walker RL; Davis S; Meltzer PS; Wheelan SJ; Brown P; Jones RJ; Shultz LD; Civin CI
Leukemia; 2010 Nov; 24(11):1859-66. PubMed ID: 20739953
[TBL] [Abstract][Full Text] [Related]
6. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.
le Viseur C; Hotfilder M; Bomken S; Wilson K; Röttgers S; Schrauder A; Rosemann A; Irving J; Stam RW; Shultz LD; Harbott J; Jürgens H; Schrappe M; Pieters R; Vormoor J
Cancer Cell; 2008 Jul; 14(1):47-58. PubMed ID: 18598943
[TBL] [Abstract][Full Text] [Related]
7. Comparison of human lung cancer/SCID mouse tumor xenografts and cell culture growth with patient clinical outcomes.
Anderson TM; Hess SD; Egilmez NK; Nwogu CE; Lenox JM; Bankert RB
J Cancer Res Clin Oncol; 2003 Oct; 129(10):565-8. PubMed ID: 12923636
[TBL] [Abstract][Full Text] [Related]
8. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice.
Flavell DJ; Warnes SL; Noss AL; Flavell SU
Br J Cancer; 2000 Dec; 83(12):1755-61. PubMed ID: 11104577
[TBL] [Abstract][Full Text] [Related]
10. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.
Hsiao M; Low J; Dorn E; Ku D; Pattengale P; Yeargin J; Haas M
Am J Pathol; 1994 Sep; 145(3):702-14. PubMed ID: 8080050
[TBL] [Abstract][Full Text] [Related]
11. Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses.
Feuer G; Stewart SA; Baird SM; Lee F; Feuer R; Chen IS
J Virol; 1995 Feb; 69(2):1328-33. PubMed ID: 7815516
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxin studies in a model of human T-cell acute lymphoblastic leukemia developed in severe combined immune-deficient mice.
Morland BJ; Boehm D; Flavell SU; Kohler JA; Flavell DJ
Cell Biophys; 1994; 24-25():315-29. PubMed ID: 7736537
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of HB2 (anti-CD7)--saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice.
Morland BJ; Barley J; Boehm D; Flavell SU; Ghaleb N; Kohler JA; Okayama K; Wilkins B; Flavell DJ
Br J Cancer; 1994 Feb; 69(2):279-85. PubMed ID: 7507691
[TBL] [Abstract][Full Text] [Related]
14. SCID mice in the study of human autoimmune diseases.
Duchosal MA
Springer Semin Immunopathol; 1992; 14(2):159-77. PubMed ID: 1475742
[No Abstract] [Full Text] [Related]
15. Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid mice.
Kamel-Reid S; Letarte M; Doedens M; Greaves A; Murdoch B; Grunberger T; Lapidot T; Thorner P; Freedman MH; Phillips RA
Blood; 1991 Dec; 78(11):2973-81. PubMed ID: 1835412
[TBL] [Abstract][Full Text] [Related]
16. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice.
Kamel-Reid S; Dick JE; Greaves A; Murdoch B; Doedens M; Grunberger T; Thorner P; Freedman MH; Phillips RA; Letarte M
Leukemia; 1992 Jan; 6(1):8-17. PubMed ID: 1531243
[TBL] [Abstract][Full Text] [Related]
17. The induction of CD10 on a pre-B leukemia cell line occurs with progression of the disease in scid mice.
Ishii E; Greaves A; Grunberger T; Freedman MH; Letarte M
Leukemia; 1993 Oct; 7(10):1592-601. PubMed ID: 7692193
[TBL] [Abstract][Full Text] [Related]
18. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Downing JR; Gunther R; Chelstrom LM; Finnegan D; Land VJ; Borowitz MJ; Carroll AJ; Crist WM
Blood; 1993 Jun; 81(11):3052-62. PubMed ID: 8098968
[TBL] [Abstract][Full Text] [Related]
19. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
